NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/15/2024
Back to search
Official data from USPTO
LTZ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/15/2024
Trademark type
Combined
Nice classes
42
Filing date
01/13/2022
Registration date
10/15/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/15/2024
Last transaction
10/15/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/04/2024
First use in commerce
07/04/2024
Drawing code
3
Owner type
03
Owner location
Redwood City, CA, US
Examiner
ROCHA, CAMERON R
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three group of lines, with each group consisting of three parallel lines, and each group of lines touching with an inner line of another group of lines at an approximately middle position, therefore forming a closed triangle with each corner having a both interior angle and exterior angle formed by one side of the triangle and the extended side, and letters "LTZ" to the right of the design.
Holders and representatives
Holders
LTZ Therapeutics Inc.
LTZ Therapeutics Inc.
Representatives
Enshan Hong MAGSTONE LAW, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; discovery and development of novel therapeutics for the treatment of multiple diseases; discovery and development of novel therapeutics for treatment of cancerautoimmune and infectious diseases
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/15/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/11/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/11/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/07/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/07/2024
IUAF
USE AMENDMENT FILED
07/08/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/08/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/28/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/02/2023
EX2G
SOU EXTENSION 2 GRANTED
10/31/2023
EXT2
SOU EXTENSION 2 FILED
10/31/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/31/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/16/2023
EX1G
SOU EXTENSION 1 GRANTED
05/12/2023
EXT1
SOU EXTENSION 1 FILED
05/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/29/2022
PUBO
PUBLISHED FOR OPPOSITION
11/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2022
DOCK
ASSIGNED TO EXAMINER
10/21/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/20/2022
NWAP
NEW APPLICATION ENTERED
01/17/2022
Continuous trademark protection
Get notified about every new filing that threatens LTZ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.